The Obesity Evolution: Framing the generic semaglutide opportunity in Canada and Brazil-20260817
高盛·2026-08-17 16:04

GLOBAL HEALTHCARE The Obesity Evolution: Framing the generic semaglutide opportunity in Canada and Brazil 17 August 2026 | 5:45AM BST Equity Research Shyam Kotadia +44(20)7051-6153 | shyam.kotadia@gs.com Goldman Sachs International Goldman Sachs Global Healthcare James Quigley +44(20)7051-3800 | james.quigley@gs.com Goldman Sachs International Gustavo Miele +55(11)3371-0834 | gustavo.miele@gs.com Goldman Sachs do Brasil CTVM S.A. Theodora Rowe Beadle +44(20)7552-0177 | theodora.beadle@gs.com Goldman Sachs I ...

The Obesity Evolution: Framing the generic semaglutide opportunity in Canada and Brazil-20260817 - Reportify